Clinical Journal of the American Society of Nephrology最新文献

筛选
英文 中文
Assessment of GFR in Patients with Cancer Part 2: Anticancer Therapies – Perspectives from the ASON 癌症患者肾小球滤过率评估第二部分:抗癌疗法--来自 ASON 的观点
IF 9.8 1区 医学
Clinical Journal of the American Society of Nephrology Pub Date : 2024-06-07 DOI: 10.2215/cjn.0000000000000509
Abhijat Kitchlu, Verônica T. Costa E Silva, Shuchi Anand, Jaya Kala, Ala Abudayyeh, Lesley A. Inker, Mitchell H. Rosner, Sabine Karam, Prakash Gudsoorkar, Shruti Gupta, Sheldon Chen, Nattawat Klomjit, Nelson Leung, Tomaz Milanez, Shveta S. Motwani, Sheikh B. Khalid, Vinay Srinivasan, Rimda Wanchoo, Jan H. Beumer, Geoffrey Liu, Nizar M. Tannir, Ani Orchanian-Cheff, Yimin Geng, Sandra M. Herrmann
{"title":"Assessment of GFR in Patients with Cancer Part 2: Anticancer Therapies – Perspectives from the ASON","authors":"Abhijat Kitchlu, Verônica T. Costa E Silva, Shuchi Anand, Jaya Kala, Ala Abudayyeh, Lesley A. Inker, Mitchell H. Rosner, Sabine Karam, Prakash Gudsoorkar, Shruti Gupta, Sheldon Chen, Nattawat Klomjit, Nelson Leung, Tomaz Milanez, Shveta S. Motwani, Sheikh B. Khalid, Vinay Srinivasan, Rimda Wanchoo, Jan H. Beumer, Geoffrey Liu, Nizar M. Tannir, Ani Orchanian-Cheff, Yimin Geng, Sandra M. Herrmann","doi":"10.2215/cjn.0000000000000509","DOIUrl":"https://doi.org/10.2215/cjn.0000000000000509","url":null,"abstract":"An abstract is unavailable. This article is available as a PDF only.","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":9.8,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141304341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
C3 Glomerulopathy Recurs Early after Kidney Transplantation in Serial Biopsies Performed within the First Two Years Post-Transplantation. 肾移植后两年内进行的连续活检显示,C3肾小球病在肾移植后早期复发。
IF 9.8 1区 医学
Clinical Journal of the American Society of Nephrology Pub Date : 2024-06-07 DOI: 10.2215/CJN.0000000000000474
Blanca Tarragón, Yonatan Peleg, Geetha Jagannathan, Miroslav Sekulic, Jae-Hyung Chang, David J Cohen, Russell J Crew, Geoffrey K Dube, Hilda E Fernandez, Syed Ali Husain, Sumit Mohan, Heather K Morris, Gerald Appel, Paresh Jadav, Dominick Santoriello, Satoru Kudose, M Barry Stokes, Ibrahim Batal, Andrew Bomback
{"title":"C3 Glomerulopathy Recurs Early after Kidney Transplantation in Serial Biopsies Performed within the First Two Years Post-Transplantation.","authors":"Blanca Tarragón, Yonatan Peleg, Geetha Jagannathan, Miroslav Sekulic, Jae-Hyung Chang, David J Cohen, Russell J Crew, Geoffrey K Dube, Hilda E Fernandez, Syed Ali Husain, Sumit Mohan, Heather K Morris, Gerald Appel, Paresh Jadav, Dominick Santoriello, Satoru Kudose, M Barry Stokes, Ibrahim Batal, Andrew Bomback","doi":"10.2215/CJN.0000000000000474","DOIUrl":"10.2215/CJN.0000000000000474","url":null,"abstract":"<p><strong>Background: </strong>C3 glomerulopathy (C3G), which encompasses C3 glomerulonephritis (C3GN) and dense deposit disease (DDD), results from dysregulation of the alternative complement pathway. Data on disease recurrence after kidney transplantation is limited, and details on histologic features of recurrent C3G are scarce. We aimed to evaluate C3G recurrence in the allograft, with a focus on histologic presentation and progression.</p><p><strong>Methods: </strong>We retrospectively analyzed 18 patients with native kidney failure attributed to C3G (12 C3GN and six DDD) who received a kidney transplant from January 2016 to January 2023. Demographic, genetic, clinical, and histologic data were studied. The Nanostring 770 genes immune profiling panel was used for transcriptomic analysis. Disease recurrence was the primary outcome.</p><p><strong>Results: </strong>During a median (IQR) follow-up period of 37 (18, 56) months, C3G recurrence occurred in 16 (89%) of patients (11 with C3GN and five with DDD), at a median (IQR) of 33 (13, 141) days post-transplantation. Over a third (38%) of recurrent cases were detected in protocol biopsies, and only 31% of patients presented with >300 mg/g of proteinuria. Recurrence in index biopsies was mainly established through a combination of immunofluorescence and electron microscopy findings, while it showed only subtle histologic alterations and no characteristic transcriptomic signals. Over time, histologic chronicity indices increased, but all allografts were functioning at the end of follow-up. Patients with recurrence of C3GN and DDD showed overlapping immunofluorescence and electron microscopy findings and had similar recurrence rate and time to recurrence.</p><p><strong>Conclusions: </strong>The majority of patients with native kidney failure attributed to C3G developed disease recurrence very early after kidney transplantation, usually with minimal proteinuria, mild histologic alterations, and favorable short-term allograft survival. Immunofluorescence and electron microscopy played a crucial role in detecting early, sub-clinical recurrence of C3GN and DDD, which showed significant overlapping features.</p>","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":9.8,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141288898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Averaged versus Persistent Reduction in Urine Output to Define Oliguria in Critically Ill Patients: An Observational Study. 一项观察性研究:用平均尿量减少与持续尿量减少来定义重症患者的少尿。
IF 8.5 1区 医学
Clinical Journal of the American Society of Nephrology Pub Date : 2024-06-07 DOI: 10.2215/CJN.0000000000000493
Céline Monard, Nathan Bianchi, Tatiana Kelevina, Marco Altarelli, Aziz Chaouch, Antoine Schneider
{"title":"Averaged versus Persistent Reduction in Urine Output to Define Oliguria in Critically Ill Patients: An Observational Study.","authors":"Céline Monard, Nathan Bianchi, Tatiana Kelevina, Marco Altarelli, Aziz Chaouch, Antoine Schneider","doi":"10.2215/CJN.0000000000000493","DOIUrl":"10.2215/CJN.0000000000000493","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":8.5,"publicationDate":"2024-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141285262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work Group. 开发 C3G 治疗方法:肾脏健康倡议 C3G 试验终点工作组的报告。
IF 8.5 1区 医学
Clinical Journal of the American Society of Nephrology Pub Date : 2024-06-03 DOI: 10.2215/CJN.0000000000000505
Carla Nester, Dima A Decker, Matthias Meier, Shakil Aslam, Andrew S Bomback, Fernando Caravaca-Fontán, Terence H Cook, David L Feldman, Veronique Fremeaux-Bacchi, Daniel P Gale, Ann Gooch, Sally Johnson, Christoph Licht, Mohit Mathur, Matthew C Pickering, Manuel Praga, Giuseppe Remuzzi, Viknesh Selvarajah, Richard J Smith, Hossein Tabriziani, Nicole van de Kar, Yaqin Wang, Edwin Wong, Kirtida Mistry, Mark Lim, Cesia Portillo, Seyi Balogun, Howard Trachtman, Aliza Thompson
{"title":"Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work Group.","authors":"Carla Nester, Dima A Decker, Matthias Meier, Shakil Aslam, Andrew S Bomback, Fernando Caravaca-Fontán, Terence H Cook, David L Feldman, Veronique Fremeaux-Bacchi, Daniel P Gale, Ann Gooch, Sally Johnson, Christoph Licht, Mohit Mathur, Matthew C Pickering, Manuel Praga, Giuseppe Remuzzi, Viknesh Selvarajah, Richard J Smith, Hossein Tabriziani, Nicole van de Kar, Yaqin Wang, Edwin Wong, Kirtida Mistry, Mark Lim, Cesia Portillo, Seyi Balogun, Howard Trachtman, Aliza Thompson","doi":"10.2215/CJN.0000000000000505","DOIUrl":"10.2215/CJN.0000000000000505","url":null,"abstract":"<p><p>Randomized clinical trials are underway to evaluate the efficacy of novel agents targeting the alternative complement pathway in patients with C3 glomerulopathy (C3G), a rare glomerular disease. The Kidney Health Initiative convened a panel of experts in C3G to ( 1 ) assess the data supporting the use of the prespecified trial end points as measures of clinical benefit and ( 2 ) opine on efficacy findings they would consider compelling as treatment(s) of C3G in native kidneys. Two subpanels of the C3G Trial Endpoints Work Group reviewed the available evidence and uncertainties for the association between the three prespecified end points-( 1 ) proteinuria, ( 2 ) eGFR, and ( 3 ) histopathology-and anticipated outcomes. The full work group provided feedback on the summaries provided by the subpanels and on what potential treatment effects on the proposed end points they would consider compelling to support evidence of an investigational product's effectiveness for treating C3G. Members of the full work group agreed with the characterization of the data, evidence, and uncertainties, supporting the end points. Given the limitations of the available data, the work group was unable to define a minimum threshold for change in any of the end points that might be considered clinically meaningful. The work group concluded that a favorable treatment effect on all three end points would provide convincing evidence of efficacy in the setting of a therapy that targeted the complement pathway. A therapy might be considered effective in the absence of complete alignment in all three end points if there was meaningful lowering of proteinuria and stabilization or improvement in eGFR. The panel unanimously supported efforts to foster data sharing between academic and industry partners to address the gaps in the current knowledge identified by the review of the end points in the aforementioned trials.</p>","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":8.5,"publicationDate":"2024-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141238792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Associations between Different Antivirals and Hospital-Acquired Acute Kidney Injury in Adults with Herpes Zoster. 成人带状疱疹患者中不同抗病毒药物与医院获得性急性肾损伤之间的关系
IF 9.8 1区 医学
Clinical Journal of the American Society of Nephrology Pub Date : 2024-06-01 Epub Date: 2024-03-26 DOI: 10.2215/CJN.0000000000000452
Ruqi Xu, Qi Gao, Yuping Zhang, Yuxin Lin, Yanqin Li, Licong Su, Shiyu Zhou, Yue Cao, Peiyan Gao, Pingping Li, Fan Luo, Ruixuan Chen, Xiaodong Zhang, Sheng Nie, Xin Xu
{"title":"Associations between Different Antivirals and Hospital-Acquired Acute Kidney Injury in Adults with Herpes Zoster.","authors":"Ruqi Xu, Qi Gao, Yuping Zhang, Yuxin Lin, Yanqin Li, Licong Su, Shiyu Zhou, Yue Cao, Peiyan Gao, Pingping Li, Fan Luo, Ruixuan Chen, Xiaodong Zhang, Sheng Nie, Xin Xu","doi":"10.2215/CJN.0000000000000452","DOIUrl":"10.2215/CJN.0000000000000452","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":9.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11168829/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140289467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Quality Systems Perspective on Sensitization and Kidney Allocation System Changes. 从质量体系的角度看敏感性和肾脏分配系统的变化。
IF 9.8 1区 医学
Clinical Journal of the American Society of Nephrology Pub Date : 2024-06-01 Epub Date: 2024-05-13 DOI: 10.2215/CJN.0000000000000478
Laurel Damashek
{"title":"A Quality Systems Perspective on Sensitization and Kidney Allocation System Changes.","authors":"Laurel Damashek","doi":"10.2215/CJN.0000000000000478","DOIUrl":"10.2215/CJN.0000000000000478","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":9.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11168821/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140917408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How We Treat Primary Hyperoxaluria Type 1. 我们如何治疗原发性高草酸尿症 1 型?
IF 9.8 1区 医学
Clinical Journal of the American Society of Nephrology Pub Date : 2024-06-01 Epub Date: 2024-03-18 DOI: 10.2215/CJN.0000000000000460
Matthew C Breeggemann, Peter C Harris, John C Lieske, Gregory E Tasian, Kyle D Wood
{"title":"How We Treat Primary Hyperoxaluria Type 1.","authors":"Matthew C Breeggemann, Peter C Harris, John C Lieske, Gregory E Tasian, Kyle D Wood","doi":"10.2215/CJN.0000000000000460","DOIUrl":"10.2215/CJN.0000000000000460","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":9.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11168812/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140144523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Calibration of Priority Points for Sensitization Status of Kidney Transplant Candidates in the United States. 校准美国肾移植候选者过敏状况的优先点。
IF 9.8 1区 医学
Clinical Journal of the American Society of Nephrology Pub Date : 2024-06-01 Epub Date: 2024-03-21 DOI: 10.2215/CJN.0000000000000449
Jesse D Schold, Anat R Tambur, Sumit Mohan, Bruce Kaplan
{"title":"Calibration of Priority Points for Sensitization Status of Kidney Transplant Candidates in the United States.","authors":"Jesse D Schold, Anat R Tambur, Sumit Mohan, Bruce Kaplan","doi":"10.2215/CJN.0000000000000449","DOIUrl":"10.2215/CJN.0000000000000449","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":9.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11168827/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140177496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Benefit of Renin Angiotensin Aldosterone Blockade in Kidney Transplant Recipients: Is the Verdict in or Still to Be Answered? 肾素血管紧张素醛固酮阻断剂对肾移植受者的益处:是结论已出还是尚待解答?
IF 9.8 1区 医学
Clinical Journal of the American Society of Nephrology Pub Date : 2024-06-01 Epub Date: 2024-05-17 DOI: 10.2215/CJN.0000000000000479
Deirdre Sawinski, Amy K Mottl
{"title":"Benefit of Renin Angiotensin Aldosterone Blockade in Kidney Transplant Recipients: Is the Verdict in or Still to Be Answered?","authors":"Deirdre Sawinski, Amy K Mottl","doi":"10.2215/CJN.0000000000000479","DOIUrl":"10.2215/CJN.0000000000000479","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":9.8,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11168816/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140959428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dialysate Sodium Lowering in Maintenance Hemodialysis: A Randomized Clinical Trial. 维持性血液透析中降低透析液钠含量的随机临床试验。
IF 8.5 1区 医学
Clinical Journal of the American Society of Nephrology Pub Date : 2024-06-01 Epub Date: 2024-02-13 DOI: 10.2215/CJN.0000000000000431
Dana C Miskulin, Hocine Tighiouart, Caroline M Hsu, Daniel E Weiner
{"title":"Dialysate Sodium Lowering in Maintenance Hemodialysis: A Randomized Clinical Trial.","authors":"Dana C Miskulin, Hocine Tighiouart, Caroline M Hsu, Daniel E Weiner","doi":"10.2215/CJN.0000000000000431","DOIUrl":"10.2215/CJN.0000000000000431","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":null,"pages":null},"PeriodicalIF":8.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11168813/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139730923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信